Title: Medical Researcher
Company: John Wayne Cancer Institute
Location: Santa Monica, California, United States
Frederick Singer, Medical Researcher at the John Wayne Cancer Institute, has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in Paget’s disease of bone research.
For more than 50 years, Dr. Singer has contributed to the field of medicine as a medical practitioner and researcher. It all started during a conversation he had with one of his high school teachers. At the time, Dr. Singer was unsure of what he wanted to do with his future and he asked the teacher for advice. The teacher had an easy answer and told him to become a doctor. With his teachers’ support behind him, Dr. Singer continued his studies in the direction of a career in medicine. He earned a Bachelor of Science from the University of California, Berkeley in 1960 and continued at the University of California, San Francisco, to receive an MD in 1963. From there, he continued his medical training as an intern at the University of California, Los Angeles and as a resident at the Veterans Affairs Hospital, completing his final residency in 1969.
In his career, Dr. Singer has research, taught and directed programs within the medical field. Since 1992, he has served as a clinical professor of medicine at the David Geffen School of Medicine at UCLA. He previously served as the Director of the Bone Center at Cedars-Sinai Medical Center. He taught for many years at the University of Southern California in assistant and associate professor positions and was an instructor of medicine at Harvard University from 1971 to 1972. At the same time, he began teaching as a clinical professor of medicine at UCLA in 1992, Dr. Singer took on the role of Director of Osteoporosis/Metabolic Bone Disease Program at St. John’s Hospital and Health Center and as the Director of Skeletal Biology Lab at the John Wayne Cancer Institute. He remains active in both of these roles. Furthermore, Dr. Singer has weighed in on matters as a member of the Endocrine and Metabolic Drug Advisory Committee for the Food and Drug Administration (FDA).
Dr. Singer served as a captain in the US Air Force from 1965 to 1967. In his research, he has focused on etiology and the treatment of Paget’s disease of bone. In addition, he has contributed to research concerning the hypocalcemia of malignancy and the pathogenesis of hypocalcemia due to magnesium deficiency. In recognition of his work and contributions to the medical field, Dr. Singer has received many accolades. Some of these include the William H. Oldendorf Lifetime Achievement Award from the West Los Angeles Veterans Affairs Medical Center, the Constellation Award from the Fibrous Dysplasia Foundation, the John Johnson Award from the Paget Foundation and a California State Scholarship.
For more information, please visit:
Contact Dr. Singer: